Stackify
Venture Round in 2019
Stackify, LLC is a developer of tools designed to enhance application performance, founded by Matt Watson in 2015 and based in Leawood, Kansas. The company specializes in cloud-based solutions that provide insights into application performance, enabling software developers to monitor and manage their applications effectively. Stackify's offerings include Prefix, which details application logs, errors, and queries, and Retrace, which delivers application performance insights and log management. The platform supports various functionalities such as application performance management, error monitoring, tracking, reporting, and application metrics monitoring. In April 2021, Stackify was acquired by Netreo, further expanding its capabilities in the realm of application performance management.
Balance the Superfood Shot
Seed Round in 2019
Balance the Superfood Shot is a Kansas City-based health supplement company founded in 2011. It develops nutritional products that promote daily fruit and vegetable intake and offers shelf-stable tonics that provide about half a day’s serving of organic produce along with essential vitamins, aiming to support preventive health. The formulations emphasize bio-available and whole-food blends to deliver nutrients conveniently for everyday use.
Flow Forward Medical
Series A in 2018
Flow Forward Medical is a company focused on enhancing vascular access sites to improve post-surgery success rates, particularly for patients undergoing hemodialysis. Founded in 2014 and headquartered in Olathe, Kansas, the company has developed the Arteriovenous Fistula Eligibility (AFE) System, which is a small, temporary external blood pump. This innovative device is designed to stimulate flow-mediated dilation of veins, thereby increasing the eligibility of patients for arteriovenous fistula (AVF) procedures and improving their surgical outcomes. By facilitating the establishment of reliable AVFs, Flow Forward Medical aims to reduce morbidity and mortality rates among hemodialysis patients and lower the overall costs associated with their care.
Artio Medical
Series A in 2018
Artio Medical, Inc. is a medical device company focused on developing and commercializing catheter-based solutions for cardiovascular diseases. Based in Olathe, Kansas, the company specializes in endovascular devices designed for embolization of vessels, aneurysms, and other vascular structures. Its product offerings include Solus Gold and Solus Flex, both embolization devices featuring unique delivery systems, as well as Aneura and Endura, which combine coils and accessory balloons for the immediate occlusion of saccular and cerebral aneurysms, respectively. Artio Medical was founded in 2011 and was previously known as Metactive Medical, Inc. before rebranding in February 2020. The company operates as a subsidiary of Novita Therapeutics, LLC, and its innovations aim to enhance the speed and safety of vascular occlusion procedures for physicians.
Artio Medical
Series A in 2017
Artio Medical, Inc. is a medical device company focused on developing and commercializing catheter-based solutions for cardiovascular diseases. Based in Olathe, Kansas, the company specializes in endovascular devices designed for embolization of vessels, aneurysms, and other vascular structures. Its product offerings include Solus Gold and Solus Flex, both embolization devices featuring unique delivery systems, as well as Aneura and Endura, which combine coils and accessory balloons for the immediate occlusion of saccular and cerebral aneurysms, respectively. Artio Medical was founded in 2011 and was previously known as Metactive Medical, Inc. before rebranding in February 2020. The company operates as a subsidiary of Novita Therapeutics, LLC, and its innovations aim to enhance the speed and safety of vascular occlusion procedures for physicians.
Rawxies
Seed Round in 2015
Rawxies LLC is a cookie production company based in Kansas City, Missouri, specializing in vegan, gluten-free, and guilt-free cookies. Founded in 2011, Rawxies offers a diverse range of flavors, including chocolate brownie, banana nut bread, chocolate chip cookie dough, cranberry pecan, lemon poppy seed, and mint chocolate chip cookies. In addition to cookies, the company provides crunch packs and assorted snack packs tailored for chocolate and fruit lovers. Rawxies markets its products through retail stores across the United States and online, catering to health-conscious consumers looking for nutritious snack options. The company also sells branded merchandise such as T-shirts, tanks, and bags through its online platform.
Nitride Solutions
Series B in 2013
Nitride Solutions Inc. is a manufacturer specializing in aluminum nitride products tailored for the electronics market. The company develops and produces aluminum nitride templates, bulk substrates, and coatings that serve various applications, including deep-UV LEDs, high-power switches, motor controls, and UV laser diodes. Their products enhance electronic device structures by maintaining thermal conductivity and voltage resistance, addressing critical challenges in power generation, transmission, and high-speed communications. Founded in 2007 and based in Wichita, Kansas, Nitride Solutions focuses on providing solutions that meet the evolving demands of the electronics industry.
EyeVerify
Series A in 2013
EyeVerify Inc. is a biometric technology company based in Kansas City, Missouri, founded in 2012. It specializes in eye-based biometric solutions for mobile devices, offering its primary product, EyePrint ID. This patented authentication solution utilizes existing smartphone cameras to capture and analyze the unique patterns of blood vessels in the eye, providing a secure and password-free mobile experience. EyePrint ID is designed to enhance data security with an encryption key equivalent to a complex 50-character password, making it suitable for use on both iOS and Android platforms. The company primarily serves businesses looking to secure customer data through its innovative biometric verification technology. As of September 2016, EyeVerify operates as a subsidiary of Ant Financial Services Group.
Aratana Therapeutics
Series C in 2013
Aratana Therapeutics, Inc. is a biopharmaceutical company dedicated to developing and commercializing therapeutics for dogs and cats in the United States. Founded in 2010 and headquartered in Leawood, Kansas, the company focuses on addressing unmet medical needs in companion animal care through high-quality medicines. Its product portfolio includes various therapeutics, such as NOCITA for post-operative pain management in dogs, ENTYCE for appetite stimulation, and GALLIPRANT for pain and inflammation associated with osteoarthritis. Aratana is also advancing treatments for conditions like osteosarcoma in dogs and a range of therapies for cats, including a specialized formulation for pain management and treatments for feline herpes virus-induced conditions. The company has established collaboration agreements with other health organizations to enhance the development and commercialization of its products.